pyridoxine 5-phosphate has been researched along with Ovarian Neoplasms in 1 studies
pyridoxine 5-phosphate: RN given refers to parent cpd
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Zhou, D | 1 |
| Guan, W | 1 |
| Ren, W | 1 |
| Sun, W | 1 |
| Shi, J | 1 |
| Lin, Q | 1 |
| Zhang, J | 1 |
| Qiao, T | 1 |
| Ye, Y | 1 |
| Wu, Y | 1 |
| Zhang, Y | 1 |
| Zuo, X | 1 |
| Connor, KL | 1 |
| Xu, G | 1 |
1 other study available for pyridoxine 5-phosphate and Ovarian Neoplasms
| Article | Year |
|---|---|
Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
Topics: Animals; Antagomirs; Base Sequence; Benzamides; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cel | 2017 |